Hormonal Contraceptives and Dermatology
Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interpl...
Gespeichert in:
Veröffentlicht in: | American journal of clinical dermatology 2021, Vol.22 (1), p.69-80 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 80 |
---|---|
container_issue | 1 |
container_start_page | 69 |
container_title | American journal of clinical dermatology |
container_volume | 22 |
creator | Williams, Natalie M. Randolph, Michael Rajabi-Estarabadi, Ali Keri, Jonette Tosti, Antonella |
description | Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interplay between hormones and the skin. This article reviews the dermatologic effects, both adverse and beneficial, of combined oral contraceptives (COCs), hormonal intrauterine devices (IUDs), implants, injections, and vaginal rings. Overall, the literature suggests that progesterone-only methods, such as implants and hormonal IUDs, tend to trigger or worsen many conditions, including acne, hirsutism, alopecia, and even rosacea. Therefore, it is worthwhile to obtain detailed medication and contraceptive histories on patients with these conditions. There is sufficient evidence that hormonal contraceptives, particularly COCs and vaginal rings, may effectively treat acne and hirsutism. While there are less data to support the role of hormonal contraceptives in other dermatologic disorders, they demonstrate potential in improving androgenetic alopecia and hidradenitis suppurativa. |
doi_str_mv | 10.1007/s40257-020-00557-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2440664297</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2564585263</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-1d3d56c70eaa94d6640183622ce8f0b668d9efd9ea7fcab2b47a8a6e5d87d9433</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlb_gAcpeNBLdJLN1x6lfkLBi55DdpMtLbubmuwK_fem3argwcMwA3nmGfIidE7ghgDI28iAcomBAgbgaeIHaEyIzDFRSh3uZo6BCzJCJzGuIJEUxDEaZVTljHE-RlfPPjS-NfV05tsumNKtu-Wni1PT2um9C43pfO0Xm1N0VJk6urN9n6D3x4e32TOevz69zO7muMwk7zCxmeWilOCMyZkVggFRmaC0dKqCQghlc1elMrIqTUELJo0ywnGrpM1Zlk3Q9eBdB__Ru9jpZhlLV9emdb6PmjIGyUpzmdDLP-jK9yF9JVFcMK44FVshHagy-BiDq_Q6LBsTNpqA3saohxh1ikbvYtQ8LV3s1X3ROPuz8p1bArIBiOmpXbjwe_sf7RfEO3vX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2564585263</pqid></control><display><type>article</type><title>Hormonal Contraceptives and Dermatology</title><source>SpringerLink Journals - AutoHoldings</source><creator>Williams, Natalie M. ; Randolph, Michael ; Rajabi-Estarabadi, Ali ; Keri, Jonette ; Tosti, Antonella</creator><creatorcontrib>Williams, Natalie M. ; Randolph, Michael ; Rajabi-Estarabadi, Ali ; Keri, Jonette ; Tosti, Antonella</creatorcontrib><description>Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interplay between hormones and the skin. This article reviews the dermatologic effects, both adverse and beneficial, of combined oral contraceptives (COCs), hormonal intrauterine devices (IUDs), implants, injections, and vaginal rings. Overall, the literature suggests that progesterone-only methods, such as implants and hormonal IUDs, tend to trigger or worsen many conditions, including acne, hirsutism, alopecia, and even rosacea. Therefore, it is worthwhile to obtain detailed medication and contraceptive histories on patients with these conditions. There is sufficient evidence that hormonal contraceptives, particularly COCs and vaginal rings, may effectively treat acne and hirsutism. While there are less data to support the role of hormonal contraceptives in other dermatologic disorders, they demonstrate potential in improving androgenetic alopecia and hidradenitis suppurativa.</description><identifier>ISSN: 1175-0561</identifier><identifier>EISSN: 1179-1888</identifier><identifier>DOI: 10.1007/s40257-020-00557-5</identifier><identifier>PMID: 32894455</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Acne ; Alopecia ; Androgens ; Baldness ; Birth control ; Dermatology ; Estrogens ; FDA approval ; Hair ; Hormones ; Medicine ; Medicine & Public Health ; Ovulation ; Pharmacology/Toxicology ; Pharmacotherapy ; Review Article ; Skin ; Skin diseases ; Transplants & implants ; Vagina ; Womens health</subject><ispartof>American journal of clinical dermatology, 2021, Vol.22 (1), p.69-80</ispartof><rights>Springer Nature Switzerland AG 2020</rights><rights>Copyright Springer Nature B.V. Jan 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-1d3d56c70eaa94d6640183622ce8f0b668d9efd9ea7fcab2b47a8a6e5d87d9433</citedby><cites>FETCH-LOGICAL-c375t-1d3d56c70eaa94d6640183622ce8f0b668d9efd9ea7fcab2b47a8a6e5d87d9433</cites><orcidid>0000-0002-3651-1019</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40257-020-00557-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40257-020-00557-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32894455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Williams, Natalie M.</creatorcontrib><creatorcontrib>Randolph, Michael</creatorcontrib><creatorcontrib>Rajabi-Estarabadi, Ali</creatorcontrib><creatorcontrib>Keri, Jonette</creatorcontrib><creatorcontrib>Tosti, Antonella</creatorcontrib><title>Hormonal Contraceptives and Dermatology</title><title>American journal of clinical dermatology</title><addtitle>Am J Clin Dermatol</addtitle><addtitle>Am J Clin Dermatol</addtitle><description>Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interplay between hormones and the skin. This article reviews the dermatologic effects, both adverse and beneficial, of combined oral contraceptives (COCs), hormonal intrauterine devices (IUDs), implants, injections, and vaginal rings. Overall, the literature suggests that progesterone-only methods, such as implants and hormonal IUDs, tend to trigger or worsen many conditions, including acne, hirsutism, alopecia, and even rosacea. Therefore, it is worthwhile to obtain detailed medication and contraceptive histories on patients with these conditions. There is sufficient evidence that hormonal contraceptives, particularly COCs and vaginal rings, may effectively treat acne and hirsutism. While there are less data to support the role of hormonal contraceptives in other dermatologic disorders, they demonstrate potential in improving androgenetic alopecia and hidradenitis suppurativa.</description><subject>Acne</subject><subject>Alopecia</subject><subject>Androgens</subject><subject>Baldness</subject><subject>Birth control</subject><subject>Dermatology</subject><subject>Estrogens</subject><subject>FDA approval</subject><subject>Hair</subject><subject>Hormones</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ovulation</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Review Article</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>Transplants & implants</subject><subject>Vagina</subject><subject>Womens health</subject><issn>1175-0561</issn><issn>1179-1888</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE1LAzEQhoMotlb_gAcpeNBLdJLN1x6lfkLBi55DdpMtLbubmuwK_fem3argwcMwA3nmGfIidE7ghgDI28iAcomBAgbgaeIHaEyIzDFRSh3uZo6BCzJCJzGuIJEUxDEaZVTljHE-RlfPPjS-NfV05tsumNKtu-Wni1PT2um9C43pfO0Xm1N0VJk6urN9n6D3x4e32TOevz69zO7muMwk7zCxmeWilOCMyZkVggFRmaC0dKqCQghlc1elMrIqTUELJo0ywnGrpM1Zlk3Q9eBdB__Ru9jpZhlLV9emdb6PmjIGyUpzmdDLP-jK9yF9JVFcMK44FVshHagy-BiDq_Q6LBsTNpqA3saohxh1ikbvYtQ8LV3s1X3ROPuz8p1bArIBiOmpXbjwe_sf7RfEO3vX</recordid><startdate>2021</startdate><enddate>2021</enddate><creator>Williams, Natalie M.</creator><creator>Randolph, Michael</creator><creator>Rajabi-Estarabadi, Ali</creator><creator>Keri, Jonette</creator><creator>Tosti, Antonella</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3651-1019</orcidid></search><sort><creationdate>2021</creationdate><title>Hormonal Contraceptives and Dermatology</title><author>Williams, Natalie M. ; Randolph, Michael ; Rajabi-Estarabadi, Ali ; Keri, Jonette ; Tosti, Antonella</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-1d3d56c70eaa94d6640183622ce8f0b668d9efd9ea7fcab2b47a8a6e5d87d9433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Acne</topic><topic>Alopecia</topic><topic>Androgens</topic><topic>Baldness</topic><topic>Birth control</topic><topic>Dermatology</topic><topic>Estrogens</topic><topic>FDA approval</topic><topic>Hair</topic><topic>Hormones</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ovulation</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Review Article</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>Transplants & implants</topic><topic>Vagina</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Williams, Natalie M.</creatorcontrib><creatorcontrib>Randolph, Michael</creatorcontrib><creatorcontrib>Rajabi-Estarabadi, Ali</creatorcontrib><creatorcontrib>Keri, Jonette</creatorcontrib><creatorcontrib>Tosti, Antonella</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of clinical dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Williams, Natalie M.</au><au>Randolph, Michael</au><au>Rajabi-Estarabadi, Ali</au><au>Keri, Jonette</au><au>Tosti, Antonella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hormonal Contraceptives and Dermatology</atitle><jtitle>American journal of clinical dermatology</jtitle><stitle>Am J Clin Dermatol</stitle><addtitle>Am J Clin Dermatol</addtitle><date>2021</date><risdate>2021</risdate><volume>22</volume><issue>1</issue><spage>69</spage><epage>80</epage><pages>69-80</pages><issn>1175-0561</issn><eissn>1179-1888</eissn><abstract>Hormones play a significant role in normal skin physiology and many dermatologic conditions. As contraceptives and hormonal therapies continue to advance and increase in popularity, it is important for dermatologists to understand their mechanisms and dermatologic effects given the intricate interplay between hormones and the skin. This article reviews the dermatologic effects, both adverse and beneficial, of combined oral contraceptives (COCs), hormonal intrauterine devices (IUDs), implants, injections, and vaginal rings. Overall, the literature suggests that progesterone-only methods, such as implants and hormonal IUDs, tend to trigger or worsen many conditions, including acne, hirsutism, alopecia, and even rosacea. Therefore, it is worthwhile to obtain detailed medication and contraceptive histories on patients with these conditions. There is sufficient evidence that hormonal contraceptives, particularly COCs and vaginal rings, may effectively treat acne and hirsutism. While there are less data to support the role of hormonal contraceptives in other dermatologic disorders, they demonstrate potential in improving androgenetic alopecia and hidradenitis suppurativa.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32894455</pmid><doi>10.1007/s40257-020-00557-5</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-3651-1019</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1175-0561 |
ispartof | American journal of clinical dermatology, 2021, Vol.22 (1), p.69-80 |
issn | 1175-0561 1179-1888 |
language | eng |
recordid | cdi_proquest_miscellaneous_2440664297 |
source | SpringerLink Journals - AutoHoldings |
subjects | Acne Alopecia Androgens Baldness Birth control Dermatology Estrogens FDA approval Hair Hormones Medicine Medicine & Public Health Ovulation Pharmacology/Toxicology Pharmacotherapy Review Article Skin Skin diseases Transplants & implants Vagina Womens health |
title | Hormonal Contraceptives and Dermatology |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T06%3A07%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hormonal%20Contraceptives%20and%20Dermatology&rft.jtitle=American%20journal%20of%20clinical%20dermatology&rft.au=Williams,%20Natalie%20M.&rft.date=2021&rft.volume=22&rft.issue=1&rft.spage=69&rft.epage=80&rft.pages=69-80&rft.issn=1175-0561&rft.eissn=1179-1888&rft_id=info:doi/10.1007/s40257-020-00557-5&rft_dat=%3Cproquest_cross%3E2564585263%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2564585263&rft_id=info:pmid/32894455&rfr_iscdi=true |